Aptevo Therapeutics Q3 EPS $(5.19) Misses $(3.89) Estimate
Benzinga Newsdesk 2 days ago
NewsEarningsEarnings Misses
This page contains a summary, not the full article. Continue to benzinga.com to read the original report.
Aptevo Therapeutics (NASDAQ:APVO) reported quarterly losses of $(5.19) per share which missed the analyst consensus estimate of $(3.89) by 33.42 percent. This is a 87.07 percent increase over losses of $(40.14) per
Aptevo Therapeutics (NASDAQ:APVO) reported quarterly losses of $(5.19) per share which missed the analyst consensus estimate of $(3.89) by 33.42 percent. This is a 87.07 percent increase over losses of $(40.14) per share from the same period last year.
